Literature DB >> 27529157

Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.

U Rüb1, K Seidel1, H Heinsen2,3, J P Vonsattel4, W F den Dunnen5, H W Korf1.   

Abstract

Huntington's disease (HD) is an autosomal dominantly inherited, and currently untreatable, neuropsychiatric disorder. This progressive and ultimately fatal disease is named after the American physician George Huntington and according to the underlying molecular biological mechanisms is assigned to the human polyglutamine or CAG-repeat diseases. In the present article we give an overview of the currently known neurodegenerative hallmarks of the brains of HD patients. Subsequent to recent pathoanatomical studies the prevailing reductionistic concept of HD as a human neurodegenerative disease, which is primarily and more or less exclusively confined to the striatum (ie, caudate nucleus and putamen) has been abandoned. Many recent studies have improved our neuropathological knowledge of HD; many of the early groundbreaking findings of neuropathological HD research have been rediscovered and confirmed. The results of this investigation have led to the stepwise revision of the simplified pathoanatomical and pathophysiological HD concept and culminated in the implementation of the current concept of HD as a multisystem degenerative disease of the human brain. The multisystem character of the neuropathology of HD is emphasized by a brain distribution pattern of neurodegeneration (i) which apart from the striatum includes the cerebral neo-and allocortex, thalamus, pallidum, brainstem and cerebellum, and which (ii) therefore, shares more similarities with polyglutamine spinocerebellar ataxias than previously thought.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  brainstem; cerebellum; cerebral cortex; pathoanatomy; polyglutamine diseases; thalamus

Mesh:

Substances:

Year:  2016        PMID: 27529157     DOI: 10.1111/bpa.12426

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  34 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

3.  Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.

Authors:  Laurent Coudert; Takashi Nonaka; Emilien Bernard; Masato Hasegawa; Laurent Schaeffer; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2019-03-12       Impact factor: 9.261

4.  Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

Authors:  Elena Vezzoli; Ilaria Caron; Francesca Talpo; Dario Besusso; Paola Conforti; Elisa Battaglia; Elisa Sogne; Andrea Falqui; Lara Petricca; Margherita Verani; Paola Martufi; Andrea Caricasole; Alberto Bresciani; Ottavia Cecchetti; Pia Rivetti di Val Cervo; Giulio Sancini; Olaf Riess; Hoa Nguyen; Lisa Seipold; Paul Saftig; Gerardo Biella; Elena Cattaneo; Chiara Zuccato
Journal:  J Clin Invest       Date:  2019-05-06       Impact factor: 14.808

5.  Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice.

Authors:  Eva L Morozko; Joseph Ochaba; Sarah J Hernandez; Alice Lau; Isabella Sanchez; Iliana Orellana; Lexi Kopan; Joshua Crapser; Janet H Duong; Julia Overman; Silvia Yeung; Joan S Steffan; Jack Reidling; Leslie M Thompson
Journal:  J Huntingtons Dis       Date:  2018

Review 6.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

7.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

8.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

9.  Caudate nucleus as a component of networks controlling behavior.

Authors:  Jonathan Graff-Radford; Lindsy Williams; David T Jones; Eduardo E Benarroch
Journal:  Neurology       Date:  2017-10-25       Impact factor: 9.910

10.  Differentiation Drives Widespread Rewiring of the Neural Stem Cell Chaperone Network.

Authors:  Willianne I M Vonk; T Kelly Rainbolt; Patrick T Dolan; Ashley E Webb; Anne Brunet; Judith Frydman
Journal:  Mol Cell       Date:  2020-04-07       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.